Remove 2023 Remove Biotech Remove Collaboration
article thumbnail

Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market

Frost & Sullivan

SAN ANTONIO – July 25, 2023 – Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizes Duopharma Biotech Berhad (Duopharma Biotech) with the 2022 Malaysian Company of the Year Award.

Biotech 97
article thumbnail

Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award

Frost & Sullivan

SAN ANTONIO – July 27, 2023 – Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizes Duopharma Biotech Berhad (Duopharma Biotech) with the 2022 Malaysian Company of the Year Award.

Biotech 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

His career highlights include igniting US reimbursement pathways for Prescription Digital Therapeutics (PDT), pioneering value-based collaboration between payers and manufacturers, and introducing groundbreaking biotech and healthtech solutions. His role involves fostering alliances within the pharmaceutical and biotech industries.

Biopharma 130
article thumbnail

Emergent Challenges in Biopharma Portfolio Management

Planview Blog

In 2023, Planview was pleased to sponsor several WHY Summit Events: Basil, Switzerland, and Philadelphia. A year later, we returned to Philadelphia and then headed cross-country to San Francisco for the WHY Summit’s 21st and 22nd American Pharma and Biotech Project, Program, and Portfolio Management Conference.

article thumbnail

Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?

Frost & Sullivan

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. What is driving transformation in the pharma industry? increase from 2022. However, the pharma/biopharma industry shows overall stagnant R&D activity.

article thumbnail

How does your company’s benchmarking performance stack up against the leading precision health companies in the ecosystem?

Frost & Sullivan

Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape. Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem.

article thumbnail

The Impact of Regulatory Changes on Healthcare Business Strategies

Jake Jorgovan

Global health trends International health trends and collaborations, including disease outbreaks and global health initiatives, can influence domestic healthcare regulations. This is evident in adopting international health standards and collaborative disease control and prevention efforts. billion in 2023 , is projected to reach $43.4

Legal 130